Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
暂无分享，去创建一个
D. Dingli | A. Dispenzieri | Shaji K. Kumar | S. Rajkumar | M. Gertz | M. Lacy | B. Laplant | S. Hayman | F. Buadi | P. Kapoor | T. Kourelis | N. Leung | R. Warsame | Y. Hwa | M. Hobbs | A. Fonder | W. Gonsalves | Eli Muchtar | M. Siddiqui | E. Wolfe | Gabriella C Malave | Angie R. Emanuel